Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company’s VASCEPA®/VAZKEPA® (Icosapent Ethyl) Franchise Well Positioned To Benefit ...

Celebrating Scientific Advancement Amarin applauds the groundbreaking work addressing sHTG and rare genetic disorders such as familial chylomicronemia syndrome (FCS). These advances help drive patient ...

Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company’s VASCEPA®/VAZKEPA® (Icosapent Ethyl) Franchise Well Positioned To Benefit ...

While the effect of VASCEPA on the risk of pancreatitis in patients with sHTG has not been determined, data from the Company’s pivotal MARINE study in patients with TGs between 500 and 2,000 mg/dL, ...
Insurance POSTOpinion

Which provider will challenge the Aviva-DLG giant in 2026?

After Aviva’s acquisition of Direct Line Group in 2025, deputy editor Scott McGee ponders what rivals could be planning to do ...

J Sainsbury Q3 Earnings Call Highlights

J Sainsbury (LON:SBRY) used its third-quarter trading statement call to highlight what Chief Executive Simon Roberts ...
Insurance Business America

Frontline Fabrics sues Chubb unit, banks over alleged $1.4 million fraud

Frontline Fabrics says hackers stole about $1.4 million via a vendor-payment scam and is suing its insurer and two banks over ...

Luigi Mangione’s federal death penalty trial could start before the end of the year

Luigi Mangione’s federal death penalty trial in the killing of UnitedHealthcare CEO Brian Thompson could begin before the end ...